Vošmik, M., John, S., Dvořák, J., Mohelníková-Duchoňová, B., Melichar, B., Lohynská, R., . . . Sirák, I. Stereotactic Radiotherapy Plus Nivolumab in Patients with Locally Advanced Pancreatic Cancer: Results from Phase 1/2 Clinical CA209-9KH Trial. Adis, Springer Healthcare.
Chicago Style (17th ed.) CitationVošmik, Milan, et al. Stereotactic Radiotherapy Plus Nivolumab in Patients with Locally Advanced Pancreatic Cancer: Results from Phase 1/2 Clinical CA209-9KH Trial. Adis, Springer Healthcare.
MLA (9th ed.) CitationVošmik, Milan, et al. Stereotactic Radiotherapy Plus Nivolumab in Patients with Locally Advanced Pancreatic Cancer: Results from Phase 1/2 Clinical CA209-9KH Trial. Adis, Springer Healthcare.
Warning: These citations may not always be 100% accurate.